Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
ATEX Extends High-Grade Porphyry Trend Intersecting 220 Metres of 1.00% CuEq Within Broader Intercept with Remaining Assays Still Pending
-
Kess Co and VIZ Media Partner to Bring Fans the Thrill of Hunter x Hunter with New Board Game
-
Denarius Metals Announces Update on Its Previously Announced Private Placement
-
Ivanhoe Mines Announces Makoko Discovery Extended to over 13 Kilometres of Strike Length
-
Scryb Increases its Ownership Position in Cybeats with a $500,000 Investment, and Open-Market Share Purchases
-
Medexus Announces Commercial Availability of GRAFAPEX (treosulfan) for Injection
-
Tantalus Systems Announces Appointment of Christopher Allen as Chief Operating Officer and Executive Vice President of Solution Strategy
-
Pulsar Helium Inc Announces Participation in Red Cloud's 13th Annual Pre-PDAC Mining Showcase
-
Building to Meet the Need for Care During Mental Health Crisis
-
Announcing the 2025 Cincinnati Consumer Choice Award Winners
-
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
-
Dow Jones to Acquire Dragonfly Intelligence and Oxford Analytica from FiscalNote
-
Tint World® celebrates million-dollar franchises, continued global success at International Franchise Convention
-
FiscalNote Announces Definitive Agreement to Divest Additional Non-Core Assets to Fuel Policy-Focused Growth, Boost Profitability, and Strengthen Balance Sheet
-
Precision BioSciences Announces Oral Presentation at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
-
Allegro MicroSystems Appoints Mike Doogue as President and Chief Executive Officer
-
BioCryst Reports Fourth Quarter and Full Year 2024 Financial Results and Upcoming Key Milestones
-
Nusano and Atomiq Collaborating to Develop Nuclear Battery Technologies
-
NEW FOUND GOLD EXPANDS HIGH-GRADE AT DOME AND GOLDEN DOME: 51.2 G/T AU OVER 13.3M & 148 G/T AU OVER 4.1M
-
MD Logic Health® and Ideal Age CEO Liz Wolfe Unveil Daily Creatine+: A Groundbreaking Formula for Holistic Wellness
-
Ceragon Brings Innovation to Life with Multiple Product Launches at MWC 2025
-
Biocon Biologics Launches Yesintek™ (ustekinumab-kfce) Biosimilar to Stelara® in the United States
-
Auron Therapeutics Announces AUTX-703 Granted Fast Track Designation by the FDA for Relapsed or Refractory Acute Myelogenous Leukemia
-
Fast Guard Service Deploys Emergency Security Teams to Protect Communities Amid Crisis
-
Capital City Bank Establishes Chief Banking Officer; Names New Chief Lending Officer
-
CENTURY LITHIUM ANNOUNCES POSITIVE RESULTS FROM OPTIMIZATION PROGRAM AT ANGEL ISLAND LITHIUM PROJECT, NEVADA
-
Vanda Pharmaceuticals announces the publication of an article titled "Potential ASO-based personalized treatment for Charcot-Marie-Tooth disease type 2S"
-
Muse Events Ready to Create Unforgettable Experiences in Portugal
-
OceanaGold Announces New Discovery and Additional High-Grade Drill Results at Haile
-
XORTX Commences Gout Program NDA Discussions with the FDA
-
Skye Bioscience to Participate in SXSW Session on Obesity
-
Ultima Genomics increases output by over 50% and lowers sequencing costs by a further 20% with the introduction of UG 100 Solaris™
-
Freightos Reports Fourth Quarter and Full Year 2024 Results
-
Gylden’s 2025 Strategic Priorities for Advancing Innovative and Transformative Solutions for Infectious Diseases
-
BOARDWALKTECH TO ANNOUNCE Q3 FISCAL 2025 FINANCIAL RESULTS ON FEBRUARY 25, 2025
-
MEDIA ADVISORY: Papa Johns Canada to Present $73,411 Donation to Second Harvest
-
Siyata Mobile Further Expands Distribution in New Agreement with IP Access International
-
Monte Rosa Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
-
Nektar Therapeutics to Host Virtual Investor & Analyst Event with Type 1 Diabetes Experts on February 24th
-
Apollo Silver Further Strengthens Board of Directors
-
Glaukos Announces FDA Acceptance of NDA Submission for Epioxa™
-
Vestar Completes the Sale of Simple Mills
-
Americas Gold & Silver Provides Galena Complex Operational and Exploration Update
-
ODL Enhances Service: Now Tempering Glass In-House
-
California Insurance Wholesalers Association (CIWA) Launches Internship Program to Foster Next Generation of Insurance Professionals
-
Healx Announces First Patient Dosed in Phase 2 Trial Evaluating HLX-1502 for the Treatment of Neurofibromatosis Type 1
-
Synnovation Therapeutics Announces Second Program to Enter the Clinic: First Patient Dosed in Phase I Trial with SNV4818, a Potential Best-In-Class Pan-Mutant-Selective PI3Kα Inhibitor for the Treatm
-
Signia Introduces Pure Charge&Go BCT IX Hearing Aids Featuring Bluetooth® Classic Connectivity with No Compromise
-
Ocular Therapeutix™ to Report Fourth Quarter and Full Year 2024 Results on March 3, 2025
-
Laser Photonics Secures Second Navy Order Through Incredible Supply & Logistics for Advanced Laser Cleaning System

